Related Funds
Fund Name | Location |
Aban Capital | - |
Amperex Technology | China, Hong Kong, New Territories |
Ascot Underwriting | England, London, United Kingdom |
AVN Business Solutions Pvt. Ltd. | Aurangabad, India, Maharashtra |
Beijing Zhonghai Jinyue Investment Management | - |
CHET Marketing | Japan, Tokyo |
Crestview Capital | Illinois, United States, Winnetka |
DigitalDx Ventures | California, San Francisco, United States |
M&A Capital | California, United States, Westlake Village |
Minnesota Zoo Hanifl Family Wild Woods | Minnesota, Minnesota City, United States |
Miracle Lab | - |
Nobska Ventures | Maryland, Stevenson, United States |
Ortel Corporation | - |
Parkwood Entertainment | New York, New York, United States |
Partnership Fund for New York City | New York, New York, United States |
Roadrunner Asset Management | Austin, Texas, United States |
THE GUILD | Chiyoda, Japan |
Union Bay Partners | Seattle, United States, Washington |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
AgenDx Biosciences | $675K | 07 Feb 2018 | South Bend, Indiana, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Torigen Pharmaceuticals | $13M | 16 Nov 2022 | Farmington, Connecticut, United States | ||
AgenDx Biosciences | $675K | 07 Feb 2018 | South Bend, Indiana, United States |